Ironwood Pharmaceuticals (IRWD) Receivables (2016 - 2025)
Historic Receivables for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $120.4 million.
- Ironwood Pharmaceuticals' Receivables rose 5800.11% to $120.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year increase of 5800.11%. This contributed to the annual value of $81.9 million for FY2024, which is 3657.16% down from last year.
- As of Q3 2025, Ironwood Pharmaceuticals' Receivables stood at $120.4 million, which was up 5800.11% from $86.2 million recorded in Q2 2025.
- In the past 5 years, Ironwood Pharmaceuticals' Receivables ranged from a high of $138.0 million in Q4 2021 and a low of $39.8 million during Q1 2025
- In the last 5 years, Ironwood Pharmaceuticals' Receivables had a median value of $119.0 million in 2023 and averaged $106.3 million.
- Its Receivables has fluctuated over the past 5 years, first tumbled by 5116.97% in 2024, then surged by 5800.11% in 2025.
- Ironwood Pharmaceuticals' Receivables (Quarter) stood at $138.0 million in 2021, then dropped by 5.8% to $130.0 million in 2022, then fell by 0.68% to $129.1 million in 2023, then tumbled by 36.57% to $81.9 million in 2024, then surged by 47.01% to $120.4 million in 2025.
- Its Receivables stands at $120.4 million for Q3 2025, versus $86.2 million for Q2 2025 and $39.8 million for Q1 2025.